Warby Parker Inc.

NYSE:WRBY

Medical - Instruments & Supplies

Healthcare
$28.22 +3.78%

+$0.92 today

Market cap
$3.07B
Beta
1.97
P/E (TTM)
2305.1
EPS (TTM)
$0.01
52W Low $14.96High $31.00

Volume 5.90M

Average 2.81M

WRBY Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Warby Parker Inc.NYSE: WRBY

Weighted Avg Shares · Q2 FY2026 · quarter ended Jun 2026

Weighted avg shares grows in line with its trailing trend

Q2 FY2026 weighted avg shares of 123.94M shares rose 1.1% year over year, in line with the +1.3% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 0.4% from the prior quarter. Over 3 fiscal years it compounded at +2.2% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +1.1% toward the trailing-twelve-month pace of +1.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
123.94M+0.4% QoQ
Last fiscal yearDec 2025
122.67M+1.9% YoY
LTMJun 2026
123.27M+1.3% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+1.1%——
1 year+1.9%——
3-year CAGR+2.2%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
122.67M USD
Year-over-year change
+1.9%
4-year CAGR
+1.9%

Weighted Avg Shares vs competitors

How WRBY compares with its peers on the latest reported figures

  • WRBY's LTM Jun 2026 weighted avg shares of 123.27M shares is the 4th highest of the 10 companies compared; the peer median is 67.93M shares.
  • Its year-over-year change of +1.3% is the 3rd highest of 10, against a peer median of +0.9%.
  • Over three fiscal years its annual growth of +2.2% compares with a peer median of +1.0%.
WRBY Competitors Peer median
Weighted Avg Shares for WRBY and competitors
Company Period LTM YoY 3-year CAGR
BHCBausch Health Companies Inc.LTM Jun 2026372.41M +0.6%+0.8%
XRAYDENTSPLY SIRONA Inc.LTM Mar 2026199.58M -1.3%-2.6%
CONConcentra Group Holdings Parent, Inc.LTM Sep 2026126.76M -0.2%+0.0%
WRBYWarby Parker Inc.LTM Jun 2026123.27M +1.3%+2.2%
BEAMBeam Therapeutics Inc.LTM Jun 2026103.26M +16.4%+12.2%
QDELQuidelOrtho CorporationLTM Mar 202667.93M +1.0%+6.1%
HAEHaemonetics CorporationLTM Jun 202646.49M -6.3%-2.4%
ITGRInteger Holdings CorporationLTM Jul 202634.56M +1.4%+1.6%
ICUIICU Medical, Inc.LTM Jun 202624.78M +1.0%+1.1%
LMATLeMaitre Vascular, Inc.LTM Mar 202622.7M +0.9%+1.0%
Peer median (excluding WRBY) 67.93M+0.9%+1.0%

Competitors are the stored peer set for WRBY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue540.8M598.11M669.77M771.32M871.91M
Cost of Revenue223.05M257.05M304.54M344.48M401.33M
Gross Profit317.75M341.06M365.22M426.83M470.58M
Gross Margin58.8%57.0%54.5%55.3%54.0%
Research & Development00000
Selling, General & Admin461.41M452.27M421.57M440.05M475.92M
Operating Expenses461.41M452.27M437.22M456.95M475.92M
Depreciation & Amortization21.87M31.86M38.55M45.87M50.28M
EBITDA(122.14M)(78.03M)(24.21M)26.35M53.32M
EBITDA Margin-22.6%-13.0%-3.6%3.4%6.1%
Operating Income(143.66M)(111.2M)(72M)(30.11M)(5.34M)
Operating Margin-26.6%-18.6%-10.7%-3.9%-0.6%
Interest Income01.31M9.23M10.6M8.38M
Interest Expense347K0000
Other Income / Expenses(347K)1.31M9.23M10.6M8.38M
Income Before Tax(144.01M)(109.9M)(62.76M)(19.52M)3.04M
Pre-Tax Margin-26.6%-18.4%-9.4%-2.5%0.3%
Income Tax Expense263K497K433K875K1.4M
Net Income(144.27M)(110.39M)(63.2M)(20.39M)1.64M
Net Margin-26.7%-18.5%-9.4%-2.6%0.2%
EPS (Basic)(1.39)(0.96)(0.54)(0.17)0.01
EPS (Diluted)(1.39)(0.96)(0.54)(0.17)0.01
Weighted Avg Shares113.62M114.94M117.39M120.39M122.67M
Weighted Avg Shares (Diluted)113.62M114.94M117.39M120.39M125.1M

Warby Parker Inc.

NYSE:WRBY

Intrinsic Alpha fair value

Locked

Current Price

$28.22

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.